Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

UNC Lineberger Comprehensive Cancer Center

A. Faso, B. Patel, K. Chen

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

Current Recommendations on Managing GI Adverse Reactions Associated …

Alberto Zambelli

Managing Dermatologic Toxicities: Cutaneous irAEs Associated with Im…

Cleveland Clinic Taussig Cancer Institute

R. Unwala

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

Diagnosis of ITP (Including Differential Diagnosis) and Disease Mana…

Drew Provan

2024 Updates on Checkpoint Inhibitor Toxicities: A Nephrology Lens

Cleveland Clinic Taussig Cancer Institute

A. Mehdi

Infectious Complications of Checkpoint Inhibitors: Discussing Overla…

Cleveland Clinic Taussig Cancer Institute

Z. Yetmar

PKD: Diagnosis, Treatment and Monitoring for Complications

Stanford Medicine

M. Chien

Thrombocytopenia: Understanding Mechanisms and Inherited Forms

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

S. Panch

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickl…

Akshat Jain

Mitapivat in PKD: Results of the ACTIVATE Trial and Updated Treatmen…

Stefan Eber

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky